TSUYOI 0.05% CRA TB 50G NEOMICINA OCREVUS® 300 mg/10 mL es

Description

OCREVUS® 300 mg/10 mL es un medicamento de uso intravenoso que contiene Ocrelizumab

COFEPRIS: 452M2016 SSA IV

00 MG PIRIDOXINA 50

un anticuerpo monoclonal indicado para el tratamiento de enfermedades inflamatorias autoinmunes

aceite mineral Vía de administración: Capilar

TSUYOI 0.05% CRA TB 50G NEOMICINA OCREVUS® 300 mg/10 mL esPRINCIPIO ACTIVO: CLOBETASOL

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy